Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced HER2-positive Breast Cancer
Interventions: DRUG: AUY922|DRUG: Trastuzumab
Sponsor: Novartis Pharmaceuticals